Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (7)

2022

  1. Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons

    International journal of molecular sciences, Vol. 23, Núm. 17

2019

  1. Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats

    Frontiers in Pharmacology, Vol. 10, Núm. SEP

2018

  1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

    Biochemical Pharmacology, Vol. 157, pp. 85-96

2015

  1. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications

    Neurotherapeutics, Vol. 12, Núm. 4, pp. 793-806

2013

  1. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?

    British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333

2012

  1. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function

    Neuropharmacology, Vol. 63, Núm. 5, pp. 776-783

2010

  1. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors

    Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440